Next Article in Journal
The Efficacy of First-Line Pembrolizumab Monotherapy in Patients with Metastatic NSCLC Aged ≥70 Years with High PD-L1 (TPS ≥ 50%) Expression: A Multicenter Real-World Study
Previous Article in Journal
TTF-1 Negativity Predicts Poor Outcomes in Advanced Non-Squamous NSCLC Also in the Immunotherapy Era: A Multicenter Cohort Study and Meta-Analysis
Previous Article in Special Issue
Serum Tumor Markers for Muscle-Invasive Bladder Cancer in Clinical Practice: A Narrative Review
 
 
Article

Article Versions Notes

Cancers 2025, 17(13), 2189; https://doi.org/10.3390/cancers17132189
Action Date Notes Link
article xml file uploaded 28 June 2025 10:27 CEST Original file -
article xml uploaded. 28 June 2025 10:27 CEST Update https://www.mdpi.com/2072-6694/17/13/2189/xml
article pdf uploaded. 28 June 2025 10:27 CEST Version of Record https://www.mdpi.com/2072-6694/17/13/2189/pdf
article supplementary file uploaded. 28 June 2025 10:27 CEST - https://www.mdpi.com/2072-6694/17/13/2189#supplementary
article html file updated 28 June 2025 10:31 CEST Original file -
article html file updated 28 August 2025 08:36 CEST Update -
article html file updated 15 September 2025 07:58 CEST Update https://www.mdpi.com/2072-6694/17/13/2189/html
Back to TopTop